Article Details

RedHill Biopharma says oral COVID-19 therapy lowered mortality in hospitalized patients ...

Retrieved on: 2022-02-08 03:51:14

Tags for this article:

Click the tags to see associated articles and topics

RedHill Biopharma says oral COVID-19 therapy lowered mortality in hospitalized patients .... View article details on hiswai:

Excerpt

Announcing data from a Phase 2/3 trial for its COVID-19 therapy opaganib, RedHill Biopharma < > said Monday that the oral treatment “significantly ...

Article found on: seekingalpha.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up